Predictive Value of Micronucleus Count in Cervical Intraepithelial Neoplasia and Carcinoma

被引:12
作者
Ambroise, Marie Moses [1 ]
Balasundaram, Kanchana [1 ]
Phansalkar, Manjiri [1 ]
机构
[1] Pondicherry Inst Med Sci, Dept Pathol, Pondicherry, India
关键词
Micronucleus tests; Uterine cervical neoplasms; Cervical intraepithelial neoplasia; Vaginal smear;
D O I
10.5146/tjpath.2013.01183
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: A micronucleus is a small additional nucleus formed due to chromosomal loss or fragmentation. The aim of this study was to assess the utility of micronucleus count as a screening tool in cervical cancer. Material and Method: A total of 132 cases consisting of 42 pre-neoplastic and neoplastic cases and 90 non-neoplastic cases were studied. Only routine Papanicolaou-stained cervical smears were used. In each smear, the number of micronucleated cells and binucleated cells were counted under oil immersion and expressed as a count per 1,000 cells. The micronucleated and binucleated cell counts in pre-neoplastic, neoplastic and non-neoplastic categories were compared for statistical significance. The counts were also correlated with age, duration of marital life, number of pregnancies and abortions. Results: The micronucleus count and the binucleated cell count were significantly higher in the high - grade squamous intraepithelial lesion (HSIL) and invasive carcinoma categories compared to low - grade squamous intraepithelial lesion (LSIL) and non-neoplastic cases. Receiver operating characteristic (ROC) curve analysis revealed that micronucleus count and binucleated cell count possess a high degree of sensitivity and specificity for identifying HSIL and invasive carcinoma. Conclusion: Our results reveal that micronucleus evaluation in routine Pap smears is a very useful biomarker in cervical cancer screening. The binucleated cell count increases the predictive value of this simple test.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 19 条
[1]   Micronuclei as biomarkers for evaluating the risk of malignant transformation in the uterine cervix [J].
Aires, G. M. A. ;
Meireles, J. R. C. ;
Oliveira, P. C. ;
Oliveira, J. L. ;
Araujo, E. L. ;
Pires, B. C. ;
Cruz, E. S. A. ;
Jesus, N. F. ;
Pereira, C. A. B. ;
Cerqueira, E. M. M. .
GENETICS AND MOLECULAR RESEARCH, 2011, 10 (03) :1558-1564
[2]   Analysis of Oral Mucosa of Users of Crack through Micronucleus Technique [J].
Almeida, Tais C. ;
Stefanon, Eliza B. C. ;
Rech, Virginia C. ;
Sagrillo, Michele R. ;
Bohrer, Paula L. .
CLINICAL LABORATORY, 2012, 58 (11-12) :1269-1275
[3]   Worldwide burden of cervical cancer in 2008 [J].
Arbyn, M. ;
Castellsague, X. ;
de Sanjose, S. ;
Bruni, L. ;
Saraiya, M. ;
Bray, F. ;
Ferlay, J. .
ANNALS OF ONCOLOGY, 2011, 22 (12) :2675-2686
[4]   Micronucleus in Atypical Urothelial Cells [J].
Arora, Sandeep Kumar ;
Dey, Pranab ;
Saikia, Uma Nahar .
DIAGNOSTIC CYTOPATHOLOGY, 2010, 38 (11) :811-813
[5]   Assessment of micronucleus frequency in normal oral mucosa of patients exposed to carcinogens [J].
Bohrer, PL ;
Sant'Ana, M ;
Paiva, RL ;
da Silva, IL ;
Rados, PV .
ACTA CYTOLOGICA, 2005, 49 (03) :265-272
[6]   Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study [J].
Castle, Philip E. ;
Stoler, Mark H. ;
Wright, Thomas C., Jr. ;
Sharma, Abha ;
Wright, Teresa L. ;
Behrens, Catherine M. .
LANCET ONCOLOGY, 2011, 12 (09) :880-890
[7]  
Cortes-Gutierrez E I, 2010, Prague Med Rep, V111, P35
[8]   Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk [J].
El-Zein, Randa A. ;
Schabath, Matthew B. ;
Etzel, Carol J. ;
Lopez, Mirtha S. ;
Franklin, Jamey D. ;
Spitz, Margaret R. .
CANCER RESEARCH, 2006, 66 (12) :6449-6456
[9]  
Campos LMFD, 2008, SAO PAULO MED J, V126, P323
[10]   Elevated frequency of Micronuclei in uterine smears of cervix cancer patients [J].
Gandhi, G ;
Kaur, B .
CARYOLOGIA, 2003, 56 (02) :217-222